104 signals · bluesky, h1b_lca, newsapi +2 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Auto-generated from public signals — AI summary pending. Based on 5 recent signals.
Hard on the heels of a £1 billion #investment package by pharma companies in last week's #UK Budget, #AbbVie has pledged another £120 million to the country, reinforcing its recovery as a #lifesciences hotspot. pharmaphorum.com/news/abbvie-...
Hard on the heels of a £1 billion #investment package by pharma companies in last week's #UK Budget, #AbbVie has pledged another £120 million to the country, reinforcing its recovery as a #lifesciences hotspot.
AbbVie Inc. (ABBV) Dividend Increase: Another Solid Raise Supports Growing Income in 2027 dividendhawk.blogspot.com/2026/11/abbv...
(ABBV) Dividend Increase: Another Solid Raise Supports Growing Income in 2027 dividendhawk.blogspot.com/2026/11/abbv...
Research-based biopharmaceutical company.
Based on 104 signals across 5 sources · snapshot 4 Nov 2026
Strong: enough recent evidence to trust this score.
Overall community sentiment for AbbVie is positive based on public signals as of 4 Nov 2026.
Based on 104 signals across 5 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
RBC Raises Price Target on AbbVie to $330 From $280, Keeps Outperform Rating marketscreener.com
OSHA (US Dept. of Labor) workplace-safety inspection of ABBVIE INC. in NORTH CHICAGO, IL (opened 2026-06-25).